LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 45.25 | 84.90 | 77 | 4539 | 0.0170 | -0.0169 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 45.25 | 84.90 | 1501 | 4539 | 0.3306 | 0.6493 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 45.25 | 84.90 | 269 | 4539 | 0.0593 | 0.2225 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 45.25 | 84.90 | 1856 | 4539 | 0.4088 | 0.7114 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 46.95 | 84.90 | 95 | 4952 | 0.0192 | 0.0194 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 46.95 | 84.90 | 1559 | 4952 | 0.3148 | 0.6423 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 46.95 | 84.90 | 286 | 4952 | 0.0577 | 0.2300 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 46.95 | 84.90 | 1916 | 4952 | 0.3869 | 0.7011 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 48.65 | 84.90 | 101 | 5328 | 0.0190 | 0.0295 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 48.65 | 84.90 | 1636 | 5328 | 0.3070 | 0.6412 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 48.65 | 84.90 | 297 | 5328 | 0.0557 | 0.2333 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 48.65 | 84.90 | 2035 | 5328 | 0.3819 | 0.7023 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 50.36 | 84.90 | 128 | 5651 | 0.0227 | 0.0701 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 50.36 | 84.90 | 1717 | 5651 | 0.3038 | 0.6429 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 50.36 | 84.90 | 294 | 5651 | 0.0520 | 0.2276 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 50.36 | 84.90 | 2062 | 5651 | 0.3649 | 0.6933 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 52.06 | 84.90 | 136 | 5990 | 0.0227 | 0.0798 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 52.06 | 84.90 | 1796 | 5990 | 0.2998 | 0.6437 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 52.06 | 84.90 | 318 | 5990 | 0.0531 | 0.2399 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 52.06 | 84.90 | 2145 | 5990 | 0.3581 | 0.6920 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 53.77 | 84.90 | 142 | 6252 | 0.0227 | 0.0865 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 53.77 | 84.90 | 1858 | 6252 | 0.2972 | 0.6446 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 53.77 | 84.90 | 344 | 6252 | 0.0550 | 0.2531 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 53.77 | 84.90 | 2261 | 6252 | 0.3616 | 0.6975 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 55.48 | 84.90 | 122 | 6567 | 0.0186 | 0.0595 | MN20160318_Q02 | F13 |